Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Teamedon International LLC
Profile last edited on: 12/16/16      CAGE: 72JF5      UEI:

Business Identifier: Acute Meloid Leukemia research
Year Founded
2014
First Award
2016
Latest Award
2016
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

10134 Treble Court
Rockville, MD 20850
   (301) 461-1617
   peter_mu@teamedon.com
   N/A
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

Teamedon International is focused on potential therapeutics for acute myeloid leukemia. Acute Myeloid Leukemia (AML) is one of worldandapos s most deadly cancers among elderly patient population with a median overall survival less than year. The persistence of leukemia stem cells LSCs following chemotherapy is a major factor contributing to clinical relapse of AML. To address this unmet medical need the firm is developing a new small molecule therapeutic selectively targets LSCs in AML.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$278,000
Phase II Dollars
$0
Total Awarded
$278,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2016 1 NIH $278,000
Project Title: A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia

Key People / Management

  Xueyan Mu

Company News

There are no news available.